| Literature DB >> 20334627 |
Shannon Weiman1, Satoshi Uchiyama, Feng-Ying C Lin, Donald Chaffin, Ajit Varki, Victor Nizet, Amanda L Lewis.
Abstract
GBS (Group B Streptococcus) requires capsular Sia (sialic acid) for virulence and partially modifies this sugar by O-acetylation. In the present paper we describe serotype-specific patterns of GBS Sia O-acetylation that can be manipulated by genetic and biochemical means. In vitro and in vivo assays demonstrate that this subtle modification attenuates GBS Sia-mediated neutrophil suppression and animal virulence.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20334627 PMCID: PMC3640289 DOI: 10.1042/BJ20100232
Source DB: PubMed Journal: Biochem J ISSN: 0264-6021 Impact factor: 3.857